Cancer immunotherapy, which uses drugs that stimulate the body's immune cells to attack tumors, is a promising approach to ...
CNN’s Christiane Amanpour revealed that her ovarian cancer has returned. The international journalist explained that although ...
4don MSN
BiTE-based immunotherapy strategy could point the way to a breakthrough for ovarian cancer patients
Results of a study led by researchers at Roswell Park Comprehensive Cancer Center show that combining two types of ...
The U.S. Food and Drug Administration (FDA) has granted fast track designation to the antibody-drug conjugate JSKN003 for the ...
The more children a woman has or whether a woman has had her fallopian tubes cut lowers the risk of different types of ovarian cancer to different levels, according to new research presented at the ...
Famed news anchor Christiane Amanpour has announced that her ovarian cancer has returned for a third time. The CNN journalist ...
Today, AbbVie (NYSE: ABBV) has announced that Canada's Drug Agency (CDA-AMC), formerly CADTH, has recommended that ELAHERE® (mirvetuximab soravtansine for injection), an antibody-drug conjugate (ADC), ...
A Prescription Drug User Fee Act target date of June 30, 2025 has been set for the application. The Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) under ...
HOUSTON — Ovarian cancer is a serious disease. Known for its subtle symptoms, it ranks as a leading cause of death for cancer affecting women’s reproductive systems. But it doesn’t have to be that way ...
I obviously had all of the relevant organs removed, but it came back a couple times in a lymph node,” the 67-year-old ...
Merck’s efforts to make headway in a cancer type that was an elusive target for its superstar oncology med Keytruda prove to ...
Veteran journalist Christiane Amanpour, who shared her ovarian cancer diagnosis in 2021, revealed she's battling the disease ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback